skinny.

Latest / Breastcancer.org Podcast

Verzenio Reduces Recurrence Risk for Certain Early-Stage Breast Cancers

Dr. Stephen Johnston is professor of breast cancer medicine and consultant medical oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London.

At the European Society for Medical Oncology Virtual Congress 2020, Dr. Johnston presented results from the monarchE trial. This study compared treating people diagnosed with early-stage hormone-receptor-positive, HER2-negative breast cancer with a high risk of recurrence with either standard hormonal therapy after surgery or two years of Verzenio (chemical name: abemaciclib) in addition to standard hormonal…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.